Literature DB >> 11023833

Cloning and characterization of full-length mouse thymidine kinase 2: the N-terminal sequence directs import of the precursor protein into mitochondria.

L Wang1, S Eriksson.   

Abstract

The subcellular localization of mitochondrial thymidine kinase (TK2) has been questioned, since no mitochondrial targeting sequences have been found in cloned human TK2 cDNAs. Here we report the cloning of mouse TK2 cDNA from a mouse full-length enriched cDNA library. The mouse TK2 cDNA codes for a protein of 270 amino acids, with a 40-amino-acid presumed N-terminal mitochondrial targeting signal. In vitro translation and translocation experiments with purified rat mitochondria confirmed that the N-terminal sequence directed import of the precursor TK2 into the mitochondrial matrix. A single 2.4 kb mRNA transcript was detected in most tissues examined, except in liver, where an additional shorter (1.0 kb) transcript was also observed. There was no correlation between the tissue distribution of TK2 activity and the expression of TK2 mRNA. Full-length mouse TK2 protein and two N-terminally truncated forms, one of which corresponds to the mitochondrial form of TK2 and a shorter form corresponding to the previously characterized recombinant human TK2, were expressed in Escherichia coli and affinity purified. All three forms of TK2 phosphorylated thymidine, deoxycytidine and 2'-deoxyuridine, but with different kinetic efficiencies. A number of cytostatic pyrimidine nucleoside analogues were also tested and shown to be good substrates for the various forms of TK2. The active form of full-length mouse TK2 was a dimer, as judged by Superdex 200 chromatography. These results enhance our understanding of the structure and function of TK2, and may help to explain the mitochondrial disorder, mitochondrial neurogastrointestinal encephalomyopathy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11023833      PMCID: PMC1221383     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  In vivo mitochondrial import. A comparison of leader sequence charge and structural relationships with the in vitro model resulting in evidence for co-translational import.

Authors:  L Ni; T S Heard; H Weiner
Journal:  J Biol Chem       Date:  1999-04-30       Impact factor: 5.157

2.  Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library.

Authors:  Y Suzuki; K Yoshitomo-Nakagawa; K Maruyama; A Suyama; S Sugano
Journal:  Gene       Date:  1997-10-24       Impact factor: 3.688

3.  A genetically distinct thymidine kinase in mammalian mitochondria. Exclusive labeling of mitochondrial deoxyribonucleic acid.

Authors:  A J Berk; D A Clayton
Journal:  J Biol Chem       Date:  1973-04-25       Impact factor: 5.157

4.  Cloning of mouse mitochondrial thymidine kinase 2 cDNA.

Authors:  K Wettin; M Johansson; X Zheng; C Zhu; A Karlsson
Journal:  FEBS Lett       Date:  1999-10-22       Impact factor: 4.124

5.  An efficient mRNA-dependent translation system from reticulocyte lysates.

Authors:  H R Pelham; R J Jackson
Journal:  Eur J Biochem       Date:  1976-08-01

6.  Deoxyribonucleoside triphosphate pool imbalances in vivo are associated with an increased retroviral mutation rate.

Authors:  J G Julias; V K Pathak
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

7.  Human thymidine kinase 2: molecular cloning and characterisation of the enzyme activity with antiviral and cytostatic nucleoside substrates.

Authors:  L Wang; B Munch-Petersen; A Herrström Sjöberg; U Hellman; T Bergman; H Jörnvall; S Eriksson
Journal:  FEBS Lett       Date:  1999-01-25       Impact factor: 4.124

8.  Human mitochondrial thymidine kinase is coded for by a gene on chromosome 16 of the nucleus.

Authors:  K Willecke; T Teber; R S Kucherlapati; F H Ruddle
Journal:  Somatic Cell Genet       Date:  1977-05

9.  Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder.

Authors:  I Nishino; A Spinazzola; M Hirano
Journal:  Science       Date:  1999-01-29       Impact factor: 47.728

10.  Thymidylate nucleotide supply for mitochondrial DNA synthesis in mouse L-cells. Effect of 5-fluorodeoxyuridine and methotrexate in thymidine kinase plus and thymidine kinase minus cells.

Authors:  D Bogenhagen; D A Clayton
Journal:  J Biol Chem       Date:  1976-05-25       Impact factor: 5.157

View more
  15 in total

1.  Structure-guided engineering of human thymidine kinase 2 as a positron emission tomography reporter gene for enhanced phosphorylation of non-natural thymidine analog reporter probe.

Authors:  Dean O Campbell; Shahriar S Yaghoubi; Ying Su; Jason T Lee; Martin S Auerbach; Harvey Herschman; Nagichettiar Satyamurthy; Johannes Czernin; Arnon Lavie; Caius G Radu
Journal:  J Biol Chem       Date:  2011-11-09       Impact factor: 5.157

2.  Phosphorylation of thymidine and AZT in heart mitochondria: elucidation of a novel mechanism of AZT cardiotoxicity.

Authors:  Edward E McKee; Alice T Bentley; Matthew Hatch; Joel Gingerich; Delia Susan-Resiga
Journal:  Cardiovasc Toxicol       Date:  2004       Impact factor: 3.231

3.  Metabolism of deoxypyrimidines and deoxypyrimidine antiviral analogs in isolated brain mitochondria.

Authors:  Kathleen A McCann; David W Williams; Edward E McKee
Journal:  J Neurochem       Date:  2012-05-21       Impact factor: 5.372

4.  The kinetic effects on thymidine kinase 2 by enzyme-bound dTTP may explain the mitochondrial side effects of antiviral thymidine analogs.

Authors:  Liya Wang; Ren Sun; Staffan Eriksson
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

5.  A few amino acid substitutions can convert deoxyribonucleoside kinase specificity from pyrimidines to purines.

Authors:  Wolfgang Knecht; Michael P B Sandrini; Kenth Johansson; Hans Eklund; Birgitte Munch-Petersen; Jure Piskur
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

6.  Regulation and functional contribution of thymidine kinase 1 in repair of DNA damage.

Authors:  Yen-Ling Chen; Staffan Eriksson; Zee-Fen Chang
Journal:  J Biol Chem       Date:  2010-06-16       Impact factor: 5.157

7.  Targeted transgenic overexpression of mitochondrial thymidine kinase (TK2) alters mitochondrial DNA (mtDNA) and mitochondrial polypeptide abundance: transgenic TK2, mtDNA, and antiretrovirals.

Authors:  Seyed H Hosseini; James J Kohler; Chad P Haase; Nina Tioleco; Tami Stuart; Erin Keebaugh; Tomika Ludaway; Rodney Russ; Elgin Green; Robert Long; Liya Wang; Staffan Eriksson; William Lewis
Journal:  Am J Pathol       Date:  2007-03       Impact factor: 4.307

Review 8.  Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function.

Authors:  Luisa Iommarini; Susana Peralta; Alessandra Torraco; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-01-29       Impact factor: 4.160

9.  Targeted deletion of both thymidine phosphorylase and uridine phosphorylase and consequent disorders in mice.

Authors:  Misako Haraguchi; Hiroaki Tsujimoto; Masakazu Fukushima; Itsuro Higuchi; Hideto Kuribayashi; Hideo Utsumi; Atsuo Nakayama; Yoshio Hashizume; Junko Hirato; Hiroki Yoshida; Hiromitsu Hara; Shinjiro Hamano; Hiroaki Kawaguchi; Tatsuhiko Furukawa; Kohei Miyazono; Fuyuki Ishikawa; Hideo Toyoshima; Tadashi Kaname; Masaharu Komatsu; Zhe-Sheng Chen; Takenari Gotanda; Tokushi Tachiwada; Tomoyuki Sumizawa; Kazutaka Miyadera; Mitsuhiro Osame; Hiroki Yoshida; Tetsuo Noda; Yuji Yamada; Shin-ichi Akiyama
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

10.  Cardiac-targeted transgenic mutant mitochondrial enzymes: mtDNA defects, antiretroviral toxicity and cardiomyopathy.

Authors:  James J Kohler; Seyed H Hosseini; Elgin Green; Amy Hoying-Brandt; Ioan Cucoranu; Chad P Haase; Rodney Russ; Jaya Srivastava; Kristopher Ivey; Tomika Ludaway; Victor Kapoor; Allison Abuin; Alexsey Shapoval; Robert Santoianni; Ann Saada; Orly Elpeleg; William Lewis
Journal:  Cardiovasc Toxicol       Date:  2008-04-30       Impact factor: 3.231

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.